Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Medical Isotopes Market Size Forecast: How Large Could The Market Become By 2030?
The medical isotopes market size has demonstrated robust growth over recent years. It is anticipated to increase from $7.26 billion in 2025 to $7.79 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion can be attributed to the widespread application of technetium 99m in diagnostics, the proliferation of hospital nuclear medicine departments, a rise in cancer diagnosis rates, the reliance on nuclear reactors for isotope supply, and ongoing progress in medical imaging equipment.
The medical isotopes market is expected to experience significant expansion in the coming years. This market is predicted to reach a valuation of $10.05 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This projected growth is driven by factors such as the increasing incidence of chronic illnesses, the rising demand for targeted radiotherapy, substantial investment in cyclotron facilities, the expansion of personalized medicine approaches, and advancements in isotope production technologies. Key developments anticipated during this period involve the growing application of radioisotopes in diagnostic procedures, the wider acceptance of nuclear medicine treatments, an increasing need for precision oncology solutions, the scaling up of cyclotron-dependent isotope manufacturing, and an intensified focus on supply chains for short-lived isotopes.
Download A Free Sample Report For Comprehensive Market Insights:
Medical Isotopes Market Expansion Drivers: What Is Shaping Future Growth?
The anticipated rise in cancer and heart disease diagnoses is poised to fuel the expansion of the medical isotope market in the coming years. These disease rates indicate the frequency of new occurrences and the overall presence of such conditions within a population over time, offering valuable insights into public health patterns and the efficacy of prevention strategies. The growing incidence of cancer and heart disease is linked to the widespread adoption of sedentary lifestyles, often encouraged by contemporary technology and desk-based professions, leading to reduced physical activity. Medical isotopes play a crucial role in both the diagnosis and treatment of cancer and heart disease, utilizing imaging methods like positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans, as well as therapeutic approaches such as radiation therapy and radioactive stents. A notable illustration of this trend comes from August 2024, where the UK-based Macmillan Cancer Support reported that over 3 million individuals in the UK were living with cancer in 2024. This number is predicted to climb to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the increasing rates of cancer and heart disease are serving as a significant impetus for the growth of the medical isotope market.
Medical Isotopes Market Segments: Where Are The Largest Growth Opportunities?
The medical isotopes market covered in this report is segmented –
1) By Product Type: Diagnostic Radioisotopes, Therapeutic Radioisotopes, Theranostic Radioisotopes
2) By Production Method: Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
3) By Application: Diagnostic Imaging, Targeted Radionuclide Therapy, Brachytherapy, Radiopharmaceutical Research & Development
4) By End Use: Hospitals, Diagnostic Imaging Centers, Research Institutes
Subsegments:
1) By Diagnostic Radioisotopes: Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Carbon-11, Other Diagnostic Radioisotopes
2) By Therapeutic Radioisotopes: Iodine-131, Lutetium-177, Yttrium-90, Strontium-89, Samarium-153, Actinium-225, Other Therapeutic Radioisotopes
3) By Theranostic Radioisotopes: Gallium-68 / Lutetium-177 Pairs, Copper-64 / Copper-67 Pairs, Iodine-123 / Iodine-131 Pairs, Scandium-44 / Scandium-47 Pairs, Terbium Isotope Pairs, Other Theranostic Radioisotopes
Medical Isotopes Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Major players in the medical isotope market are focusing on strategic partnerships to boost their competitive position. Such collaborations entail structured arrangements between various entities, formed to attain precise, predetermined, and reciprocally beneficial goals. For instance, in September 2023, International Isotopes Inc., a US-based medical technology firm, partnered with Phantech Medical, a US-based biomedical hardware company, with the intention of combining their offerings for customers. Via this joint effort, their objective is to revolutionize the calibration and reference sources market for pre-clinical imaging by concentrating on the conception, manufacture, and supply of sophisticated sealed sources tailored for the medical imaging and theranostics sectors.
Medical Isotopes Market Major Participants And Competitive Dynamics
Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien München AG (ITM), Eczacibasi-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotóp, Coquí RadioPharmaceuticals Corp., Jubilant DraxImage Inc.
Access The Complete Medical Isotopes Market Report:
Medical Isotopes Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the medical isotopes market in 2025. The regions covered in the medical isotopes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
